Ratings by
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 11/14/2016 | N/A | Impax Laboratories | IPXL | Downgrade | () |
N/A (N/A) |
15.00 (18.30) |
22% | Details |
| 7/7/2016 | N/A | VistaGen Therapeutics | VTGN | New Coverage | (N/A) |
17.00 (N/A) |
3.75 (0.26) |
-93.07% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 65 more... | |||||||||
